Dendritic Cell Based Therapy of Malignant Melanoma

NCT00197912 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Advanced Melanoma

Interventions

BIOLOGICAL: tumor antigen loaded autologous dendritic cells

Sponsor

Herlev Hospital